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Coronaviruses cause a variety of respiratory and enteric diseases in animals and humans including severe
acute respiratory syndrome. In these enveloped viruses, the filamentous nucleocapsid is formed by the
association of nucleocapsid (N) protein with single-stranded viral RNA. The N protein is a highly immunogenic
phosphoprotein also implicated in viral genome replication and in modulating cell signaling pathways. We
describe the structure of the two proteolytically resistant domains of the N protein from infectious bronchitis
virus (IBV), a prototype coronavirus. These domains are located at its N- and C-terminal ends (NTD and CTD,
respectively). The NTD of the IBV Gray strain at 1.3-Å resolution exhibits a U-shaped structure, with two arms
rich in basic residues, providing a module for specific interaction with RNA. The CTD forms a tightly
intertwined dimer with an intermolecular four-stranded central -sheet platform flanked by  helices, indi-
cating that the basic building block for coronavirus nucleocapsid formation is a dimeric assembly of N protein.
The variety of quaternary arrangements of the NTD and CTD revealed by the analysis of the different crystal
forms delineates possible interfaces that could be used for the formation of a flexible filamentous ribonucleo-
capsid. The striking similarity between the dimeric structure of CTD and the nucleocapsid-forming domain of
a distantly related arterivirus indicates a conserved mechanism of nucleocapsid formation for these two viral
families.
Coronaviridae is a family of viruses which are the causative
agents of human upper respiratory infections including com-
mon colds, as well as severe illnesses such as severe acute
respiratory syndrome (SARS). Avian infectious bronchitis vi-
rus (IBV) is a major source of mortality in chickens worldwide
and has a significant impact on the poultry industry. Other
coronaviruses affect domestic animals and are of veterinary
significance. Coronaviruses are enveloped viruses with a diam-
eter ranging from 80 to 160 nm. Their viral genome consists of
positive-sense single-stranded (ss) RNA of approximately 30
kb (36). The genomic RNA encodes a 3 coterminal set of four
or more subgenomic mRNAs with a common leader sequence
at their 5 ends. These subgenomic RNA segments encode
various structural and nonstructural viral proteins that are re-
quired to produce progeny virions. The viral particle consists of
a nucleocapsid or core structure surrounded by a lipid enve-
lope in which the membrane glycoprotein (M) and another
small transmembrane protein (E) are embedded. A series of
protrusions composed of glycoproteins (S) anchored in the
lipid envelope extend radially, forming up to 20-nm-long spikes
which give the roughly spherical viral particles a crown (co-
rona) appearance.
During the virus life cycle, multiple copies of the nucleocap-
sid phosphoprotein (N) interact intimately with genomic and
subgenomic RNA molecules (1, 28) and together with M, the
most abundant envelope protein, participate in genome con-
densation and packaging. The N and M proteins interact via
their C termini, leading to specific genome encapsidation in
the budding viral particle (19). Electron microscopic studies of
detergent-permeabilized transmissible gastroenteritis virus
capsids revealed that the internal ribonucleocapsid is a flexible
filamentous structure with a diameter of approximately 10 to
15 nm and up to several hundred nanometers in length (33,
34). The highly basic N protein has a molecular mass ranging
between 45 and 60 kDa in the various groups of coronaviruses
and, along with its coding RNA, is synthesized in large
amounts during infection (20, 37). The N protein is able to
bind ssRNA nonspecifically but displays an increased affinity
for viral genomic RNA (9). Packaging signals have been iden-
tified at the 5 and 3 termini of the genome for several coro-
naviruses, but not unambiguously for the IBV genome. Bio-
chemical studies of murine hepatitis virus (MHV), IBV, and
SARS coronavirus (SARS-CoV) have mapped the RNA bind-
ing function to a segment of 55 residues located at the N-
terminal half of the N protein and the dimerization function to
its C-terminal half (14, 29, 45). In addition to its structural role,
the N protein is also implicated in other processes during
infection including mRNA transcription, replication, and host
cell modulation (16, 20, 25, 35, 39, 41, 44). The N protein is
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also an important diagnostic marker for coronavirus disease
and a major immunogen that can prime protective immune
responses (23).
The recombinant N protein of coronavirus expressed in
Escherichia coli is highly susceptible to proteolysis, making
structural analysis of the full-length protein difficult. To date,
there is only limited information on the structure of the ribo-
nucleocapsid protein, including a nuclear magnetic resonance
(NMR) analysis of the N-terminal domain of the SARS-CoV
N protein (18) and our crystallographic study of the N-terminal
domain of the IBV N protein (Beaudette strain) at 1.85-Å
resolution (14). As yet, there is no X-ray crystallographic struc-
ture analysis of the C-terminal dimerization domain of a coro-
navirus N protein. In this paper, we present a structural anal-
ysis, at high resolution, of the two proteolytically stable
domains of the IBV N proteins located at the N- and C-
terminal ends, called NTD and CTD, respectively. The NTD
structure of IBV (Gray strain), determined to a 1.3-Å resolu-
tion, is similar to the previously published Beaudette strain
(12) but makes strikingly different quaternary associations. We
describe the first crystal structure of the CTD dimerization
domain of the coronavirus N protein at a resolution of 2.2 Å.
Our X-ray crystallographic analysis of the NTD and CTD
provides insight into the way these modules might interact with
RNA and with the M protein. The various crystal forms also
delineate a number of alternative protein surfaces that are
likely to be used for the formation of a flexible filamentous
ribonucleocapsid.
MATERIALS AND METHODS
Purification of full-length nucleocapsid protein and limited proteolysis. The
full-length N protein was expressed as described previously (47). The protein was
further purified by heparin affinity chromatography, concentrated to 1 to 2 mg/ml
and checked for homogeneity using dynamic light scattering (Dynapro) and
negative-stain electron microscopy. Limited proteolytic cleavage of the full-
length N protein (1 to 2 mg/ml) was carried out with 2% (weight trypsin/weight
protein) sequencing-grade trypsin (Roche) to identify stable domains. The iden-
tity of the amino termini of the proteolytic product(s) was determined by N-
terminal amino acid sequencing of the band following gel electrophoresis and
blotting onto a polyvinylidene fluoride membrane (PVDF-Immobilon-PSQ; Mil-
lipore). For construct optimization the identities of the carboxy-terminal amino
acids were estimated based on secondary structure prediction and mass spectro-
metric characterization of the proteolyzed protein.
Cloning, expression, purification, and crystallization of the tryptic fragments
of N protein. The NTD and CTD proteins from two strains were employed in this
study, namely, IBV Gray (CTD1, CTD2, and NTD1) and IBV Beaudette
(CTD3) (Fig. 3). The proteins were cloned and expressed as glutathione S-
transferase fusion proteins using the pet41 Ek-LIC vector (Novagen) or, for the
Beaudette strain, as detailed previously (14) The expressed protein was purified
using a glutathione S-Sepharose (Pharmacia) affinity column, followed by on-
bead cleavage with enterokinase (EK-Max, Invitrogen). The cleavage reaction
was performed by suspending 1 ml of beads in 40 ml of cleavage buffer (250 mM
NaCl, 50 mM Tris-HCl [pH 8.0]) with 10 units of protease. Following proteolysis,
the diluted supernatant was further purified by gel filtration chromatography on
a Superdex 75 16/60 column (Pharmacia). The purified N- and C-terminal do-
mains were concentrated to 5 to 8 mg/ml for crystallization.
Data collection and phasing. Diffraction data were collected at various syn-
chrotron beam lines as indicated in Table 1. For each crystal, images were
collected using an oscillation angle of 1° and integrated and scaled with
HKL2000 (31). For the NTD, the diffraction data to 1.3 Å were phased using
molecular replacement (MR) procedures in PHASER (38), using the previously
published NTD structure (PDB ID, 2BTL) at 2.8-Å resolution (14). Following
MR, further model building and refinement were performed in a similar manner
to that for the CTD as described below. The CTD crystallized in three crystal
forms (Table 1). Its structure was determined using selenomethionine (Se-Met)-
substituted protein with crystal form CTD1 (Table 1) using multiwavelength
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anomalous dispersion data sets collected at two different wavelengths (Se peak,
0.9734 Å; Se inflection, 0.9748 Å). Positions of the four Se atoms were located
using the SnB program (43) and refined using SHARP (overall figure of merit of
0.65) (2). An electron density map was calculated following density modification
using CCP4 (8). An initial model was built using ARP/WARP (21) followed by
manual model building using Coot (13). A few cycles of simulated annealing
were performed with CNS (3) followed by model refinement using REFMAC5
(32). The structures of CTDs in the two other crystal forms (CTD2 and CTD3)
were solved using MR procedures as implemented in PHASER (23). Model bias
in both NTD and CTD structures was reduced by using the prime-and-switch
technique implemented in SOLVE/RESOLVE (42). During the course of model
building and refinement, the stereochemistry of the structures was checked by
PROCHECK (22). The final statistics are provided in Table 2. Surface electro-
static potentials were calculated using DELPHI (30). All figures were generated
using PyMOL (10) and ESPript (15).
Protein structure accession numbers. The coordinates for the molecules were
deposited into the PDB with accession numbers 2GE7 (CTD1), 2GE8 (CTD2),
2CA1 (CTD3), and 2GEC (NTD1).
RESULTS
Identification of two stable independent domains of IBV N
by limited proteolysis. Since the full-length recombinant pro-
tein aggregated and was degraded under a variety of experi-
mental conditions, we sought to identify stable domains that
were resistant to mild proteolysis. We used limiting amounts of
trypsin and V8 protease. The digestion pattern with the V8
protease was not very distinct, yielding several diffuse bands.
FIG. 1. Structural domains of the IBV N protein and structure of the NTD RNA binding domain. (A) Schematic diagram showing the major
(arrow) and minor trypsinization sites (short vertical line) following limited proteolysis of the full-length IBV N protein. The locations of the N-
and C-terminal domains (NTD spanning residues 19 to 162 and CTD spanning residues 219 to 349) are depicted as black rectangles. (B) Ribbon
representation of the 1.3-Å structure of the NTD (Gray strain) asymmetric homodimer (molecules A and B as indicated). The region
corresponding to the disordered internal arm is depicted in orange. (C) The NTD (Beaudette strain) determined by Fan et al. (14). (D) Elec-
trostatic potential surface of the linear array of NTD dimers generated by the crystallographic translation. Molecules A and B that constitute the
dimer are indicated. The N-terminal arm and the region corresponding to the internal arm, rich in basic residues, are indicated by black and cyan
arrows, respectively. The disordered loop in the B molecule is indicated by a dotted line (see the text).
TABLE 2. Refinement statistics
Domain (PDB code) PDB CTD1 (2GE7) PDB CTD2 (2GE8) CTD3 (2CA1) PDB NTD1 (2GEC)
Resolution range (Å) 50–2.0 48–2.2 20–2.6 50–1.3
Number of reflections 15,110 48,564 8,941 60,751
Rfactora 0.238 0.236 0.204 0.210
Rfreeb 0.269 0.291 0.256 0.250
Mean bond length deviation 0.005 0.006 0.009 0.008
Mean bond angle deviation 1.305 1.318 1.176 1.235
Ramachandran statistics
Residues in most-favored regions (%) 94.2 91.6 89.8 88.6
Residues in additional allowed regions (%) 5.8 7.6 10.2 10.4
Residues in generously allowed regions (%) 0.6 0.5
Residues in disallowed (poor density) regions (%) 0.2 0.5
a Rfactor  	 Fobs 
 Fcalc/	 Fobs.
b Rfree was calculated with 10% of reflections excluded from the whole refinement procedure.
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The full-length protein, however, could be cleaved into a “sin-
gle” stable 17-kDa band within 15 min of trypsinization. N-
terminal sequencing allowed the identification of four tryptic frag-
ments with two major cleavage sites at residues 19 and 219 and
two secondary cleavage sites at residues 27 and 226 (Fig. 1A).
New constructs corresponding to these proteolytically resis-
tant domains termed NTD (residues 19 to 162) and CTD
(residues 219 to 349) were cloned, expressed, and purified. The
NTD was monomeric at moderate protein concentrations,
whereas the CTD was a dimer even at very low concentrations,
as assayed by gel filtration chromatography (12). The NTD and
CTD proteins tended to aggregate during the purification pro-
cedure and thus purified at very low concentrations and con-
centrated only prior to crystallization.
NTD and CTD crystallized in multiple crystal forms. The
recently reported structure of NTD at 1.85-Å resolution cor-
responds to the Beaudette strain of IBV. We used the IBV
Gray strain which crystallized in a different crystal form and
diffracts to 1.3-Å resolution (Table 1, crystal form NTD1). The
CTD yielded crystals with needle, rod, flat sheet, or hexagonal
shapes under various conditions (Table 1, crystal forms CTD1,
CTD2, and CTD3). Rod-shaped CTD1 crystals of Se-Met sub-
stituted protein diffracting to 2.0 Å were used for structure
determination. The structures of CTD in the other crystal
forms (CTD2 at 2.2-Å and CTD3 at 2.6-Å resolution) were
determined subsequently by molecular replacement. These
various crystal forms exhibit different packing arrangements, a
number of which could mimic the intermolecular interactions
that trigger the formation of the coronavirus nucleocapsid.
High-resolution structure of NTD. With the exception of
five additional residues discernible at its N terminus, the
present structure of NTD of IBV Gray strain is quite similar to
the structure of the NTD of IBV Beaudette strain (Fig. 1C)
(14). Briefly, the NTD monomer features a relatively acidic
globular core of twisted antiparallel -sheet surrounded by
several loop regions. Prominent among the loop regions are
two long segments corresponding to the N-terminal 12 amino
acids (residues 22 to 34) and an internal arm spanning residues
74 to 86. These loops protrude from the globular core resulting
in a “U”-shaped monomer (Fig. 1B).
A dimer of NTD subunits is present in the crystallographic
asymmetric unit: two interlocking NTD monomers are ar-
ranged in a head-to-tail fashion with the basic arms of one
monomer interacting with the acidic base of the other mono-
mer (Fig. 1B). The main structural variation between the two
NTD monomers related by noncrystallographic symmetry is
that in one monomer, one of the arms of the “U” (internal
arm) is disordered. The buried surface area of 2,150 Å2
between the two NTD monomers indicates a rather strong
interaction. This is in contrast with the previous structure of
FIG. 2. Structure of the CTD dimerization domain. The left panel shows a ribbon representation of the “front” and “back” of the CTD dimer
related by a rotation of 180° about the vertical axis, and the right panel shows the electrostatic potential surface of the dimer in the same
orientations, in which the positively charged surface is represented in shades of blue and the negatively charged surface in shades of red. Left, the
intertwined CTD dimer is formed by exchanging two  strands and one  helix between the two monomers (“domain swapping”). The two
monomers, in yellow and gray, respectively, are related by a noncrystallographic twofold axis of symmetry approximately perpendicular to the plane
of the figure. The  strands from both monomers form an extended antiparallel -sheet floor flanked by several  helices. Secondary structural
elements are labeled. Right, a large patch of positively charged residues (blue) that could be involved in RNA binding is visible on one of the faces
of the CTD protein (bottom).
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NTD (14), where the U-shaped monomers were kept parallel
but which had a much smaller buried surface area of only 590
Å2 (Fig. 1C).
The structure of CTD is a tightly intertwined dimer. In all
three crystal forms obtained, the CTD exists as a tightly inter-
twined twofold symmetric dimer (Fig. 2) with two  strands
and one  helix from one monomer making extensive contacts
with the other monomer and burying a total surface of approx-
imately 5,000 Å2 in their interaction. The distribution of sec-
ondary structure elements along the CTD amino acid sequence
and the topology of the CTD dimer are shown in Fig. 3. The
CTD dimer has a rectangular shape delimited by edges formed
by the C-terminal  helices 5 (Fig. 2) with approximate di-
mensions of 40 Å  40 Å  20 Å. It features a concave floor
of 400-Å2 area consisting of an antiparallel  sheet (1A-
2A-2B-1B) contributed by monomers A and B, respec-
tively, surrounded by several  helices and one short 310 helix
(Fig. 2). Helices 3 and 4 are connected by a loop and,
together with their dimeric partners, form a groove which
arches inward over this floor constituting the other mostly
basic face of the CTD dimer. Recent biochemical and mass
spectrometric studies on the IBV N protein (Beaudette strain)
have suggested the possibility of disulfide bridges in the CTD
(5). However, no intramolecular disulfide bridge is seen in the
CTD dimer of either strain of IBV reported here. The present
structure of the CTD is consistent with previous observations
that the CTD is a dimer in solution, with several biochemical
studies which map the dimerization domain of the full-length
protein to its C-terminal domain (40, 45).
Multiple packing modes of CTD dimers. The CTD dimer is
involved in various intermolecular interactions in the three
crystal forms reported here. The presence of one dimer (CTD1
and CTD3) and four dimers in the asymmetric unit of the
CTD2 crystal form (Tables 1 and 2) permits an analysis of
dimer-dimer interactions in various conditions of precipitant
and pH. We focused on interactions with a buried surface area
larger than 1,000 Å2. Such an analysis could help in the iden-
tification of molecular surfaces that are used to assemble the
nucleocapsid.
CTD1 dimers (pH, 4.5) which are related by the crystal-
lographic 21 screw axis display three kinds of intermolecular
contacts. One interaction (burying 1,100 Å2) brings two
dimers in a tail-to-tail fashion (referred to as type S) (Fig. 4A).
Interestingly, in the CTD2 form which crystallized at pH 8.5, a
similar contact is observed between three of the four crystal-
lographically independent dimers (Fig. 4B). However, unlike
in CTD1, where the dimers form an infinitely long linear array,
a small swivel between the three CTD2 dimers (dimers 1, 2,
and 3) introduces a slight curvature. In both crystal forms, type
S interactions are mediated by C-terminal residues located
between positions 308 and 328, which include  helix 5 and a
type II turn. A network of water-mediated polar interactions
and a salt bridge between residues Arg 308 and Asp 314 are
observed (Fig. 4A, bottom). Secondly, a lateral interaction
between dimers 2 and 4 (Fig. 4B) mediated by their N-terminal
residues (221 to 230) buries a comparable surface area of
1,250 Å2 (type L). Dimer 4 extends the helical array formed
by dimers 1, 2, and 3 in a lateral manner (Fig. 4B [type S]).
Finally, in the CTD3 crystal form, dimers form a long helical
polymer that spirals along the 43 screw axis, with a buried
surface area of 1,085 Å2 (type F). These interactions medi-
ated by hydrogen bonds between Arg 230 of one monomer and
carbonyl atoms from residues 263 to 266 in the other monomer
bear some resemblance to the type L interactions seen in
CTD1 and CTD2. These contacts result in an infinitely prop-
agating tube of CTD3 molecules with a diameter of approxi-
mately 60 Å (Fig. 4C and 5B). Interestingly, this arrangement
of CTD subunits would place the RNA binding N-terminal
domains towards the interior of the tube and the C-terminal
domains pointing outside.
DISCUSSION
A flexible filamentous nucleocapsid formed by the close
association of N proteins with viral genomic RNA is a common
feature in many enveloped ssRNA viruses including coronavi-
ruses. Structural information on the N protein and a molecular
FIG. 3. Structure-based alignment of coronavirus nucleocapsid amino acid sequences corresponding to the CTD dimerization domain.
Secondary structure elements are labeled above the sequence for the IBV CTD dimerization domain (this work). Sequences for IBV N proteins
were obtained from Swiss-Prot (IBV-G [Gray strain], P32923; IBV-B [Beaudette strain], P69596). Sequences for human coronavirus (H-CoV;
strain HKU1, YP_173242); MHV (strain 1, AAA46439); SARS (SARS-CoV, NCAP_CVHSA) and porcine transmissible gastroenteritis virus
(TGEV; strain RM4, AAG30228) were obtained from GenBank. Helices (310 and  helices) are shown as squiggles and  strands as arrows. Boxes
indicate residues that are fully or partially conserved. Fully conserved residues are shaded in red. Partially conserved residues are indicated by
salmon-pink letters.
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understanding of how this protein facilitates the formation of
the nucleocapsid are limited. From the biochemical character-
ization of the N protein of IBV, a prototypical coronavirus,
presented here, it is apparent that this protein has two major
protease-resistant domains. Our X-ray crystallographic analy-
sis of these two domains, NTD and CTD, provides some in-
sights into how the two-domain organization of the N protein
may coordinate nucleocapsid assembly.
Interaction of N with RNA. Biochemical studies (14, 29)
have located the RNA binding site in the N-terminal domain
with the minimal region being mapped to residues 177 to
231 in MHV (corresponding to residues 136 to 190 in IBV).
In addition to the NTD, an involvement of the CTD in RNA
binding has been shown by Fan et al. (14). Based on the
structure of the NTD (IBV Beaudette strain), we proposed
that the basic arms of the U-shaped monomer participate in
RNA binding. This hypothesis is consistent with an NMR-
heteronuclear single quantum coherence analysis of NTD-
RNA interactions that was carried out for the SARS coro-
navirus N protein (18). A novel finding from our crystal
structure analysis is the presence of strong interlocking
dimers of the NTD (IBV Gray strain). This is in contrast
with the weak dimeric interaction observed in the NTD of
the IBV Beaudette strain reported earlier (14). These in-
terlocking dimers associate to form a linear fiber with the
basic tethers exposed along the surface. Such fibers could
provide for closely packed interactions of NTD with the
viral genomic RNA. Analysis of N protein-RNA interactions
in MHV at different stages of the virus life cycle revealed
that these interactions progress from an RNase-sensitive
complex involving subgenomic RNA to an RNase-resistant
complex involving genomic RNA (28). The strong and weak
NTD dimer interactions seen in the two structures could
correspond to these different states of N protein-RNA as-
sociations. The electrostatic potential surface of the CTD dimer
shows one of its faces significantly more basic than the other, with
a groove lined by -helices 3 and 4 that could interact with
RNA (Fig. 2 and 5A and B).
FIG. 4. Crystal-packing interactions between CTD dimers. (A) Crystal-packing interactions in CTD1 crystals grown at pH 4.5, with one dimer
in the asymmetric unit (ASU). Three consecutive dimers from the neighboring ASU (numbered n, n  1, and n 
 1) related by one of the three
orthogonal 21 screw axes are shown (type-S interaction). Each monomer has been given a different color. The N- and C-terminal ends for the n 
1 are indicated. The salt bridge interaction between dimers n and n 
 1 seen in the type-S interface is circled. A closeup view of the salt bridge
interaction with an electron density map is shown in the inset below. (B) Interactions between the four CTD dimers present in the CTD2 ASU
(pH 8.5). Each dimer is shown in a different color and numbered from 1 to 4. The two classes of dimer-dimer interactions are indicated by S
(between molecules 1 and 2 and molecules 2 and 3) and L (between molecules 2 and 4). The bridging type-S interactions are shown with molecule
4 from two adjacent ASUs and molecules 1, 2, and 3 from the neighboring ASU (all shown in gray). (C) Dimer-dimer interactions observed in the
CTD3 crystals having one CTD dimer in the ASU (type F). Each dimer related by the crystallographic 43 screw axis is shown in a different color.
This type of packing gives rise to hollow tubes, as is evident from a projection along the fiber axis (along the c axis) below shown in red.
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Interaction between the N and M proteins. In addition to
their interactions with RNA, N proteins also interact with the
M proteins embedded in the viral membrane. Based on reverse
genetic-complementation assays, the interaction region be-
tween these two proteins has been mapped to their C termini
(19). The C terminus of the M protein is significantly basic, and
recent mutational studies on the M protein have demonstrated
that its interaction with the N protein is predominantly elec-
trostatic in nature (26). The exposed acidic -sheet floor, on
the opposite side of the proposed RNA-binding region in the
CTD dimer, may promote such an interaction. Thus, the CTD
may serve a dual purpose of mediating the self-association of
the N protein during nucleocapsid formation but also of pro-
viding a complementary surface for interaction with the
endodomain of the M protein in the virus envelope.
Possible model for nucleocapsid formation. The formation
of the coronavirus nucleocapsid involves self-association of the
N protein and interaction with RNA resulting in a structure
which is RNase resistant. Our crystal structure analysis of CTD
reveals a tight dimer mediated by an exchange of secondary
structure elements (domain swapping), thus suggesting that
the full-length N protein also functions as a dimer, with the
CTD providing a structural scaffold while the NTD mainly
serves as a module for RNA interaction. The relative orienta-
tion of the NTD with respect to the CTD in the N protein
remains unknown, because in the full-length protein these two
domains are connected by a 47-residue protease-sensitive loop,
rich in Ser and Gly residues, which is presumably mobile. In
the filamentous ribonucleocapsid, thanks to the flexibility pro-
vided by this linker, the RNA binding regions of these two
domains could face each other, engulfing the RNA between
them, thus conferring resistance to RNases.
In the various crystal forms studied, the NTD and CTD
self-associate in multiple modes with buried surface areas
greater than 1,000 Å2. A relevant question is which (if any) of
these interactions are used in the formation of the nucleocap-
sid. Both the type-S and -F interactions between CTDs are
conducive to the formation of fibril structures. Propagation of
FIG. 5. A possible model for helical nucleocapsid formation. (A) Electrostatic potential surface of the CTD polymer formed through S
interactions in the CTD2 crystals. (B) View of the electrostatic potential surface of the assembly formed by the close association of five CTD dimers
related by the 43 screw axis, from neighboring-unit cells, as observed in the CTD3 crystals. The grooves lined by basic  helices are well exposed
to the solvent and could thus participate in viral genomic RNA binding. (C) A possible model for the nucleocapsid formation based on the
protein-protein interfaces observed in the crystallographic structures of the NTD and CTD domains of IBV. The NTD dimers (gray spheres)
provide specific binding to the viral genomic RNA (black line). Secondary contacts with RNA with polymers of CTD are formed so that together
the viral genome is condensed in a protective flexible tube. The CTD dimers (shown in red and green) could interact via type-S interface. Changes
in the curvature and/or the direction of the nucleocapsid filament would derive from the incorporation of another type of isoenergetic interfaces
(e.g., type-S, type-L, or type-F interactions). (D) This arrangement is reminiscent of the assemblies formed by the PRRSV capsid-forming domain
(PDB ID, 1P65) (11).
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any single type of interactions, however, would lead to a rigid
helical nucleocapsid. Considering that the coronavirus nucleo-
capsid is not a rodlike structure, nucleocapsid assembly may
thus involve a combination of the various interactions observed
in our studies. The type-S interface could be used to a greater
extent given that it occurs over a wider range of pH and seems
to form regardless of the constraints imposed by crystal-pack-
ing forces (as in the CTD2 crystals). A combination of the
type-S interactions with types L and F would modulate the
curvature of the nucleocapsid in the virion (Fig. 5C).
Similarity with other coronavirus N proteins. Coronaviruses
have been classified into four groups, with SARS-CoV being
the founding member of an independent group. The N protein
sequences are more similar within each group (40% identity)
than across groups (20 to 30% identity). The only X-ray struc-
ture of a coronavirus N protein available to date is that of the
IBV NTD protein as described here and by Fan et al. (14).
Despite very low sequence similarity between IBV and the
SARS-CoV N proteins, their NTD and CTD structures adopt
the same general polypeptide fold. This suggests that this fold
is essentially preserved across the various coronavirus groups.
This conclusion is also consistent with the NMR structures of
the N- and C-terminal domains of the SARS N protein re-
ported recently (4, 18).
Comparison with the N proteins of other positive-strand
ssRNA viruses. Crystal structures of nucleocapsid proteins
from several other positive-strand ssRNA viruses, including
porcine reproductive and respiratory syndrome virus (PRRSV)
in the Arteriviridae (11), West Nile virus in the Flaviviridae (12),
and Sindbis virus and Semliki Forest virus in the Togaviridae
family (6, 7), have been reported. The C-terminal domains of
nucleoproteins from Sindbis virus and Semliki Forest virus
adopt a chymotrypsinlike -barrel fold. Core proteins from
West Nile and dengue virus are dimers composed entirely of
-helical bundles. As indicated by a systematic structural ho-
mology search (17), the coronavirus N protein CTD closely
resembles the nucleocapsid protein of PRRSV. The PRRSV
capsid-forming domain (C-terminal 73 to 123 amino acid res-
idues) has a similar dimeric structure and exhibits self-associ-
ation mediated by a salt bridge as seen in the IBV CTD (11)
(Fig. 5D). Although a “domain-swapping” mode of oligomer-
ization has been observed in a variety of proteins which are
known to self-aggregate (24), the nature of domain swapping
observed in these two viral proteins appears to be unique.
Interestingly, unlike the CTD fold which is shared with the
arterivirus PRRSV, the fold of the NTD is observed only in the
coronavirus N proteins (14). The corresponding basic N-ter-
minal RNA binding domain in the much shorter PRRSV N
protein appears to be largely disordered (11). Thus, the ob-
served structural similarity between the N proteins of IBV and
PRRSV suggests that members of the Coronaviridae and
Arteriviridae families (order Nidovirales) share a common mech-
anism of filamentous nucleocapsid formation with suitable al-
terations necessary to interact specifically with their respective
genomes. Conversely, the structural differences with other nu-
cleocapsid proteins from ssRNA enveloped viruses, such as
flaviviruses and togaviruses, probably reflect variations in their
replication strategies and assembly pathways. Indeed, flavivi-
ruses and togaviruses exhibit icosahedrally symmetric exteriors
and are not pleomorphic like coronaviruses (27, 46). One com-
mon feature in the nucleocapsid proteins across positive-strand
ssRNA viruses, however, appears to be the partitioning of the
nucleocapsid protein structure into two domains: one forming
a protective scaffold around the RNA through self-association
and the other providing specific interactions with the viral
genome. Electron-microscopic studies of ribonucleocapsid as-
semblies at higher resolution are now needed in order to gain
further insights into the molecular mechanism of nucleocapsid
formation for coronaviruses. However, we hope that the
atomic description of the N protein provided here will stimu-
late such studies and also the design of molecules that could
disrupt viral assembly.
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